Related Experiment Video
Updated: Mar 31, 2026
06:43
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.9K
Do glia drive synaptic and cognitive impairment in disease?
Won-Suk Chung1, Christina A Welsh2, Ben A Barres1
1Department of Neurobiology, Stanford University School of Medicine, Palo Alto, California 94305, USA.
Nature Neuroscience
|October 28, 2015
Summary
Glia actively influence brain synapses, and their dysfunction contributes to neurodegenerative diseases. Understanding neuron-glia signaling may reveal new therapeutic targets for synaptic and cognitive impairments.
Area of Science:
- Neuroscience
- Cell Biology
- Neuroimmunology
Background:
- Synaptic dysfunction is a key feature of brain disorders.
- Glia were historically considered passive responders to neuronal damage.
- Emerging evidence highlights glia's active role in neuron signaling.
Purpose of the Study:
- To explore the role of glia in synaptic vulnerability.
- To investigate how neuron-glia signaling impacts brain function.
- To identify glia-mediated mechanisms contributing to cognitive impairment.
Main Methods:
- Review of current literature on neuron-glia interactions.
- Analysis of glia's secreted and contact-dependent signaling pathways.
- Examination of glia's influence on synaptic development, transmission, and plasticity.
Main Results:
- Glia actively modulate synaptic function through diverse signaling mechanisms.
- Disruptions in neuron-glia communication are implicated in synaptic dysfunction.
- Reactive gliosis is a prominent feature in CNS diseases, suggesting glial involvement.
Conclusions:
- Neuron-glia signaling is crucial for maintaining synaptic health.
- Altered glia function contributes to cognitive deficits in neurological disorders.
- Targeting neuron-glia interactions may offer novel therapeutic strategies for brain diseases.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:04Glial Cells
96.7K
Overview
96.7K
01:28Disorders of the Nervous Tissue
3.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.1K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
836
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
836
01:29Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K